Results 241 to 250 of about 782,827 (325)

Bilateral Peritonsillar Abscesses Subsequent to Coronavirus Disease 2019 (COVID-19): A Case Report. [PDF]

Cureus
Ominato H, Kumai T, Ota R, Takahara M.
europepmc   +1 more source

Human brain matters: Navigating the neuropathology of COVID‐19

Brain Pathology, EarlyView.
Severe COVID‐19 is associated with vascular dysregulation and chronic neuroinflammation, leading to axonal injury and neurodegeneration. In long COVID or PASC, persistent alterations in neuroimaging and biofluid biomarkers reflect ongoing neuronal damage and neuroinflammation, contributing to long‐term neurological symptoms including fatigue, cognitive
Juliana M. Nieuwland, Angelica Scaramuzza, Marianna Bugiani, Wilma D. J. van de Berg, Jinte Middeldorp   +4 more
wiley   +1 more source

Hospital Breastfeeding Support during the Early Coronavirus Disease 2019 (COVID-19) Pandemic: Worsening Care for Black, Hispanic, and Asian Mothers. [PDF]

Matern Child Health J
Lazar Tucker J, Arcoleo K, DiTomasso D, Oaks BM, Cabral H, São-João T.   +5 more
europepmc   +1 more source

Targeting protein–protein interactions with reversible covalent modalities: Non‐cysteine chemistries

British Journal of Pharmacology, EarlyView.
Abstract Protein–protein interactions (PPIs) are central to diverse cellular functions, and represent a rapidly expanding class of therapeutic targets. Advancements in covalent drug design have enabled small‐molecule drugs to overcome challenges associated with engaging these targets, such as limited durations of action and difficult‐to‐drug (expansive,
Ruchira Basu, Steven Fletcher
wiley   +1 more source

Post-coronavirus Disease 2019 (COVID-19) Cardiovascular Manifestations: A Systematic Review of Long-Term Risks and Outcomes. [PDF]

Cureus
Idris Fadul AA, Osman Mohamed AA, Mohammed Ahmed AAS, Elmobark S, Merghani Hammour AS, Elgaleel Khir Elsiad NMN, Mohammed Elhaj EA.   +6 more
europepmc   +1 more source

Mast Cells in Acute COVID‐19 Patients

Allergy, EarlyView.
Ilan Zaffran, Hadas Pahima, Eli Ben‐Chetrit, Amir Jarjoui, Ilaria Puxeddu, Carl Zinner, Joana Vitte, Alexandar Tzankov, Francesca Levi‐Schaffer   +8 more
wiley   +1 more source

PLGA‐particle‐based vaccine induces SARS‐CoV‐2‐specific antibody and T‐cell responses

British Journal of Pharmacology, EarlyView.
A novel coronavirus disease 2019 (COVID‐19) vaccine encapsulating recombinant severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) spike receptor binding domain (RBD) with the double stranded RNA (dsRNA) analogue Riboxxim induces robust systemic and respiratory T‐ and B‐cell responses in mice.
Dennis Horvath, Katharina Inholz, Dennis Mink, Alicia Madel, Julia Koerner, Reinhold Horlacher, Michael Basler   +6 more
wiley   +1 more source

Successful Treatment of Post-coronavirus Disease 2019 (COVID-19) Autoimmune Encephalitis With Plasmapheresis After a Failed Trial of Steroids. [PDF]

Cureus
Kamel T, Toppen W, Salahmand Y.
europepmc   +1 more source

Coronavirus disease 2019 (COVID-19) vaccine acceptability in Ghana: An urban-based population study. [PDF]

PLoS One
Taylor-Abdulai HB, Dzantor EK, Mensah NK, Asumah MN, Ocansey S, Arhin SK, Barnes P, Opoku VO, Mankir ZJ, Famieh SA, Botchey CPK.   +10 more
europepmc   +1 more source

Nutritional and Physical Rehabilitation in Post-Critical Coronavirus Disease 2019 (COVID-19) Ambulatory Patients: The NutriEcoMuscle Study. [PDF]

Nutrients
Joaquín C, Bretón I, Ocón-Bretón MJ, Zabalegui A, Bellido D, Matía Martín P, Martínez-Olmos MÁ, Zugasti A, Riestra M, Botella F, García-Almeida JM, NutriEcoMuscle Study Team.   +11 more
europepmc   +1 more source